-
-
不限 301 304 401 402 403 404 大会议厅B(4楼) 大宴会厅A（3楼） 大宴会厅B（3楼） 大宴会厅D（3楼） 多功能B (1楼) 多功能C (1楼) 新闻发布厅A (2楼) 新闻发布厅B (2楼) 新闻发布厅C 新闻发布厅D 205 206 207 101 102A 102B 102C 103A 103B 103C 论文交流区（3F） 线上（VIP 5） 307 大宴会厅C（3楼） 308 城山厅D 湘浦厅 护理培训工坊 线上手术频道 城山厅A 城山C 病例展示区（3F） 导管室分会场 城山厅ABC 手术转播区（3F） 大会议厅A-1(4楼） 大会议厅A-2(4楼） 大会议厅A-3(4楼） JACC Express Box 区域（2F） 培训工坊（3F） 滨江分会场
Frontiers in Hypertrophic Cardiomyopathy Forum
|
08:00-10:00 大宴会厅C（3楼） |
|---|
| 主席 Chairmen | 王建安 Jianan WANG, 陈韵岱 Yundai CHEN | ||
| 主持 Moderators | 张健 Jian ZHANG, 金玮 Wei JIN | ||
|
08:00-08:05 |
开场视频 Opening Video |
||
|
08:05-08:15 |
领势向心：主席致辞 Leading Forward, Uniting Together- Chairman's Opening |
||
|
08:15-08:35 |
负重前行：中国肥厚型心肌病诊疗的多维挑战 The Burdened Journey: Multifaceted Challenges in Diagnosis and Treatment HCM in China |
杜昕 Xin DU | |
|
08:35-08:55 |
创新驱动：从药理机制到临床验证： 新型CMI药物的创新探索 Innovation Driven: From Pharmacological Mechanisms to Clinical Validation — Exploring Next in Class CMI Therapeutics |
蒋学俊 Xuejun JIANG | |
|
08:55-09:15 |
未来破局：新型CMI药物的最新研究数据 Future Directions: Latest Research Data on Next in Class CMI Drugs |
张书宁 Shuning ZHANG | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
王江 Jiang WANG | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
孙志军 Zhijun SUN | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
修建成 Jiancheng XIU | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
陈玉成 Yucheng CHEN | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
李浪 Lang LI | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
高传玉 Chuanyu GAO | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
陈新敬 Xinjing CHEN | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
彭道泉 Daoquan PENG | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
陶凌 Ling TAO | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
苑海涛 Haitao YUAN | |
|
09:55-10:00 |
会议总结 Meeting Summary |
||
Lipid Forum-3
|
10:00-12:00 大宴会厅C（3楼） |
|---|
| 主席 Chairman | 王建安 Jianan WANG | ||
| 主持 Moderators | 刘斌 Bin LIU, 王焱 Yan WANG, 高传玉 Chuanyu GAO, 鄢华 Hua YAN | ||
|
10:00-10:05 |
大会主席致辞 Opening Remarks |
待定 Ding DAI | |
|
10:05-10:25 |
ESC 2025热点聚焦：中国原研PCSK9i 助力血脂管理新方案 ESC 2025 Highlights: China's Indigenous PCSK9 Inhibitor Contributes to Novel Lipid-Management Strategies |
施仲伟 Zhongwei SHI | |
|
10:25-10:45 |
从单抗发展史看中国企业的创新与突破 Innovation and Breakthroughs of Chinese Enterprises: Perspectives from the Evolution of Monoclonal Antibodies |
史旭波 Xubo SHI | |
|
10:45-11:05 |
PCI术后高效血脂管理策略 Strategies for Efficient Lipid Management Post-Percutaneous Coronary Intervention |
陆峰 Feng LU | |
|
11:05-11:25 |
FLAVOUR IV：使用PCSK9抑制剂进一步降脂对冠状动脉CT血管造影提示的高危斑块的心血管结局影响 Further Lipid-Lowering with PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography |
胡新央 Xinyang HU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
周建华 Jianhua ZHOU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
于雪 Xue YU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
陈样新 Yangxin CHEN | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
曲新凯 Xinkai QU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
薛玉增 Yuzeng XUE | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
袁杰 Jie YUAN | |
|
11:55-12:00 |
总结 Summary |
待定 Ding DAI | |
Valvular Heart Disease Forum–7
|
13:30-15:30 大宴会厅C（3楼） |
|---|
|
Session 3 东南钙化菁英俱乐部年度精彩病例汇报 |
||||
|---|---|---|---|---|
| 主席 Chairman | 王建安 Jianan WANG | |||
| 主持 Moderator | 王力涵 Lihan WANG | |||
|
13:30-13:33 |
开场视频 Opening Ceremony Video |
|||
|
13:38-13:43 |
开场致辞 Opening Ceremony Address |
|||
|
13:38-13:43 |
致欢迎语 Welcoming Remarks |
|||
|
13:48-13:53 |
全国专家寄语视频 National Experts' Video Messages |
|||
|
13:48-13:53 |
启动仪式 Launch Ceremony |
|||
|
13:53-13:55 |
合影 Group Photo |
|||
|
前沿进展 · 规范实践 |
||||
|---|---|---|---|---|
| 主席 Chairmen | 王焱 Yan WANG, 袁义强 Yiqiang YUAN, 张俊杰 Junjie ZHANG | |||
| 主持 Moderators | 方臻飞 Zhenfei FANG, 傅国胜 Guosheng FU, 罗建方 Jianfang LUO, 陶凌 Ling TAO, 杨毅宁 Yining YANG, 李永在 Yongzai LI | |||
| 讨论嘉宾 Discussants | 丛广志 Guangzhi CONG, 何晋 Jin HE, 李林锋 Linfeng LI, 周浩 Hao ZHOU | |||
|
13:55-14:10 |
J-VALVE TF 两年随访数据解读 Interpretation of Two-Year Follow-Up Data of J-VALVE TF |
刘先宝 Xianbao LIU | ||
|
14:10-14:25 |
首款经血管入路反流瓣产品特点介绍&讨论 The Pioneer Transvascular Anti-Regurgitation Valve: Product Profile and Technical Discussion |
吴永健 Yongjian WU | ||
|
14:25-14:40 |
AR介入治疗研究进展及AR专用器械的临床优势 Research Progress in AR-Assisted Interventional Therapy and Clinical Advantages of AR-Specific Devices |
陈韵岱 Yundai CHEN | ||
|
14:40-14:55 |
经血管入路TAVR治疗AR标准手术流程详解&讨论 Transvascular TAVR for Aortic Regurgitation: A Comprehensive Review of the Technique |
Dongming HOU | ||
|
14:55-15:10 |
首款经血管入路反流瓣的前世今生与创新之路 The First Transvascular Valve for Aortic Regurgitation: From Concept to Clinical Reality |
蓝天翔 Tianxiang LAN | ||
|
15:10-15:30 |
首款经血管入路反流瓣 在复杂病例中的应用&讨论 Application and Discussion of the First Transvascular Reflux Valve in Complex Cases |
Simon LAM | ||
Frontline Management Forum
|
15:30-18:00 大宴会厅C（3楼） |
|---|
| 主持 Moderators | 周华 Hua ZHOU, 蒋天武 Tianwu JIANG, 杜兆辉 Zhaohui DU, 葛承辉 Chenghui GE, 张磊 Lei ZHANG | ||
| 讨论嘉宾 Discussants | 徐文杰 Wenjie XU, 杨建敏 Jianmin YANG, 陈碧华 Bihua CHEN, 严培玲 Peiling YAN | ||
|
15:30-15:35 |
开场致辞 Opening Remarks |
待定 Ding DAI | |
|
15:35-15:55 |
创新防控模式 提升管理效能 ——关于慢性病防控工作的思考与建议 Innovating Prevention and Control Models to Enhance Management Efficiency ——Reflections and Suggestions on Chronic Disease Prevention and Control Work |
赵振平 Zhenping ZHAO | |
|
15:55-16:15 |
浙江省基层慢病防控情况介绍 Introduction to CHC Prevention and Control of Chronic Diseases in Zhejiang Province |
钟节鸣 Jieming ZHONG | |
|
16:15-16:35 |
三甲医院在我国慢病防控工作中的职责与担当 The Role and Responsibility of Tertiary Hospitals in Chronic Disease Prevention and Control in China |
陈雯艾 Wenai CHEN | |
|
16:35-16:55 |
H2H血压达标案例分享 H2H Blood Pressure Target Achievement Case Sharing |
但淑杰 Shujie DAN | |
|
16:55-17:15 |
县域医共体慢性病一体化管理体系构建与探索 Development and Exploration of an Integrated Management System for Chronic Diseases within County Healthcare Consortiums |
吴斌 Bin WU | |
|
17:15-17:35 |
“优效化？个体化？ — 高质量控压的关键策略思辨” “Optimization? Personalization? — A Critical Examination of Key Strategies for High-Quality Blood Pressure Management” |
谢建洪 Jianhong XIE | |
|
17:35-17:55 |
讨论 Discussion |
||
|
17:55-18:00 |
总结 Summary |
||